Compare HTZ & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTZ | NVCR |
|---|---|---|
| Founded | 1918 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1997 | 2015 |
| Metric | HTZ | NVCR |
|---|---|---|
| Price | $5.55 | $13.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $5.05 | ★ $26.42 |
| AVG Volume (30 Days) | ★ 5.2M | 1.0M |
| Earning Date | 02-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,516,000,000.00 | $642,269,000.00 |
| Revenue This Year | N/A | $9.68 |
| Revenue Next Year | $3.35 | $6.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $3.26 | $10.70 |
| 52 Week High | $9.39 | $27.32 |
| Indicator | HTZ | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 49.97 |
| Support Level | $5.33 | $12.80 |
| Resistance Level | $6.14 | $14.29 |
| Average True Range (ATR) | 0.32 | 0.70 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 36.27 | 29.14 |
Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.